
Eloxx Pharmaceuticals ELOX
Quarterly report 2023-Q3
added 11-13-2023
Eloxx Pharmaceuticals Current Ratio 2011-2025 | ELOX
Annual Current Ratio Eloxx Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.665 | 1.98 | 2.63 | 4.89 | 6.45 | 0.103 | 2.66 | 4.79 | 3.96 | 1.1 | 1.12 | 1.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.45 | 0.103 | 2.66 |
Quarterly Current Ratio Eloxx Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.23 | 0.24 | 0.31 | 0.66 | 0.84 | 1.06 | 1.37 | 1.98 | 2.47 | 3.04 | 1.16 | 1.63 | 1.63 | 1.63 | 1.63 | 2.59 | 2.59 | 2.59 | 2.59 | 6.5 | - | - | - | - | 7.56 | 4.98 | 7.61 | 1.06 | 2.07 | 1.24 | 1.98 | 2.26 | 2.8 | 2.67 | 2.67 | 2.81 | 4.93 | 5.7 | 5.7 | 3.28 | 1.57 | 2.14 | 2.14 | 1.41 | 1.72 | 1.99 | 1.99 | 1.7 | 1.91 | 2.11 | 2.11 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.61 | 0.23 | 2.49 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
3.18 | $ 223.98 | -0.53 % | $ 396 B | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
3.76 | $ 4.67 | 1.74 % | $ 775 M | ||
|
Aclaris Therapeutics
ACRS
|
3.4 | $ 3.36 | 2.75 % | $ 260 M | ||
|
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
Ascendis Pharma A/S
ASND
|
0.918 | $ 210.16 | 4.43 % | $ 5 B | ||
|
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
3.71 | $ 1.33 | -1.48 % | $ 7.25 M | ||
|
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.42 | 2.09 % | $ 8.23 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 25.9 | 0.74 % | $ 1.25 B | ||
|
AstraZeneca PLC
AZN
|
1.65 | $ 90.29 | - | $ 96.9 B | ||
|
Anika Therapeutics
ANIK
|
14.4 | $ 9.49 | - | $ 139 M | ||
|
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
1.47 | $ 2.28 | - | $ 14.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | ||
|
Biogen
BIIB
|
2.47 | $ 172.5 | - | $ 25.1 B | ||
|
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | ||
|
Benitec Biopharma
BNTC
|
43.4 | $ 12.96 | 1.17 % | $ 533 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
3.08 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
2.08 | $ 581.03 | 2.22 % | $ 44 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 0.29 | -0.31 % | $ 631 M | ||
|
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
6.16 | - | -16.75 % | $ 25.8 M | ||
|
Catalyst Biosciences
CBIO
|
3.06 | $ 15.31 | - | $ 1.01 B | ||
|
Clovis Oncology
CLVS
|
0.629 | - | -7.23 % | $ 13 M | ||
|
Cerus Corporation
CERS
|
1.4 | $ 2.15 | 13.76 % | $ 397 M | ||
|
BioVie
BIVI
|
8.46 | $ 1.51 | -4.43 % | $ 2.23 M | ||
|
Cortexyme
CRTX
|
2.03 | - | -1.05 % | $ 67.1 M | ||
|
Celldex Therapeutics
CLDX
|
17.5 | $ 27.94 | - | $ 1.8 M | ||
|
Cellectar Biosciences
CLRB
|
0.467 | $ 3.78 | -5.97 % | $ 46.2 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 | $ 11.44 | 7.92 % | $ 740 M | ||
|
BioNTech SE
BNTX
|
7.22 | $ 96.0 | - | $ 27.2 B | ||
|
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | ||
|
Enochian Biosciences
ENOB
|
0.278 | - | - | $ 40.5 M | ||
|
Epizyme
EPZM
|
9.33 | - | - | $ 249 M |